ALKERMES | Costo Del Venduto



Cost Of Sales Cambiamento Data
AbbVie USD 4.35B 344M 2025-06
Acadia Pharmaceuticals USD 20.73M 342K 2025-06
ALKERMES USD 49.46M 263K 2025-06
Amgen USD 3.01B 406M 2025-06
Biogen USD 605M 24.3M 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
J&J USD 7.6B 304M 2025-06
Malin Corporation EUR 15.4M 0 2020-12
Merck USD 2.82B 53M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Otsuka Holdings JPY 168.78B 12.13B 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


ALKERMES Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.